21-03-2013 дата публикации
Номер: US20130071449A1
An implantable device including a conjugate formed of an acrylamide-based copolymer and a bioactive agent is provided. 2. The implantable device of claim 1 , wherein the linker comprises succinic anhydride claim 1 , glutaric anhydride claim 1 , dimethyl succinic anhydride claim 1 , methyl glutaric anhydride claim 1 , a thioester claim 1 , a disulfide bond claim 1 , a PLA-oligomer claim 1 , a PLGA-oligomer claim 1 , a PCL-oligomer claim 1 , an ester linkage claim 1 , or an anhydride linkage.3. The implantable device of claim 1 , wherein the linker comprises succinic anhydride claim 1 , glutaric anhydride claim 1 , dimethyl succinic anhydride claim 1 , or methyl glutaric anhydride.4. The implantable device of claim 1 , wherein the linker comprises poly(ethylene glycol) (PEG) claim 1 , an alkyl chain claim 1 , or a peptide sequence.5. The implantable device of claim 4 , wherein the peptide sequence comprises glycine-phenylalinine-leucine-glycine.6. The implantable device of claim 1 , wherein the linker comprises poly(ethylene glycol) (PEG) claim 1 , poly(alkylene oxide) claim 1 , C1-C12 alkyl claim 1 , C1-C12 cycloalkyl claim 1 , or C1-C12 aryl.7. The implantable device of claim 1 , wherein the copolymer is poly[N-(2-hydroxypropyl)methacrylamide-co-methoxyethyl methacrylate] (HPMA-co-MOEMA).8. The implantable device of claim 1 , wherein the copolymer is a random or block copolymer.9. The implantable device of claim 1 , which is a stent.10. The implantable device of claim 1 , wherein the bioactive agent is selected from the group consisting of halofuginone claim 1 , paclitaxel claim 1 , docetaxel claim 1 , estradiol claim 1 , 17-beta-estradiol claim 1 , a nitric oxide donor claim 1 , super oxide dismutase claim 1 , a super oxide dismutase mimic claim 1 , 4-amino-2 claim 1 ,2 claim 1 ,6 claim 1 ,6-tetramethylpiperidine-1-oxyl (4-amino-TEMPO) claim 1 , tacrolimus claim 1 , dexamethasone claim 1 , rapamycin claim 1 , a rapamycin derivative claim 1 , 40-O-(2-hydroxy)ethyl- ...
Подробнее